Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2024 Aug 18:12:20503121241271820.
doi: 10.1177/20503121241271820. eCollection 2024.

Exploring patient's perspective of barriers to diabetic medication adherence in Jazan, Saudi Arabia, using the social determinants of health model

Amani Khardali  1   2 , Alanood Aladwani  1   2 , Fahad Alzahrani  3 , Osama A Madkhali  4 , Saad Al Qahtani  5 , Marwa Qadri  6   7 , Morghma Deffeallah Adawi  8 , Mohammed Hakamy  8
Affiliations

Exploring patient's perspective of barriers to diabetic medication adherence in Jazan, Saudi Arabia, using the social determinants of health model

Amani Khardali et al. SAGE Open Med. .

Abstract

Background: Type 2 diabetes mellitus is usually associated with long-term macrovascular and microvascular complications that negatively impact the patient's quality of life and add economic burden to the healthcare system. Understanding patients' perspectives on medication nonadherence is essential for planning the appropriate methods and strategies to improve medication adherence among patients with uncontrolled diabetes.

Aim: Therefore, this study aims to explore patients' perceptions of the barriers to medication adherence through the Social Health determinants framework.

Method: After obtaining ethical approval, qualitative face-to-face interviews with a sample of patients with type 2 diabetes mellitus (uncontrolled diabetes) were conducted. Interviews were audio-recorded, and then the data were analyzed using thematic analysis to identify essential themes related to the patient's views.

Results: Fifteen patients with type 2 diabetes mellitus were interviewed. Potential barriers to antidiabetic medications were identified and categorized based on the Social Determinants of Health domains. The patient's health perceptions and behaviors were found to positively or negatively impact medication adherence. Beliefs toward antidiabetic medications, polypharmacy, medication-related problems, and the relationship between patients and their healthcare providers that related to healthcare access and quality domains were also reported as potential barriers to medications. Financial constraints, social stigma, and family support were other social health determinants factors that were found to have either positive or negative impacts on adherence. Nevertheless, using mobile health applications was suggested to facilitate medication adherence.

Conclusion: Social Determinants of Health, such as education about type 2 diabetes mellitus, quality and access to healthcare, and social stigma and support, might significantly affect medication adherence among type 2 diabetes mellitus patients. This study's findings can aid the development of suitable patient-specific tools and strategies to enhance medication adherence.

Keywords: Type-II diabetes mellitus; barriers; medication adherence; qualitative.

PubMed Disclaimer

Conflict of interest statement

The author(s) declared no potential conflicts of interest with respect to the research, authorship, and/or publication of this article.

Figures

Figure 1.
Figure 1.
Themes for T2DM medication adherence based on the social determinant of health domain.
See this image and copyright information in PMC

References

    1. International Diabetes Federation. IDF Diabetes Atlas | Tenth Edition. Diabetes Atlas, https://diabetesatlas.org/ (2021).
    1. WHO. Diabetes Fact sheet. Geneva, Switzerland: World Health Organization, https://www.who.int/news-room/fact-sheets/detail/diabetes (2022).
    1. Nathan DM, Buse JB, Davidson MB, et al.. Medical management of hyperglycemia in type 2 diabetes: a consensus algorithm for the initiation and adjustment of therapy. Diabetes Care 2009; 32(1): 193–203. - PMC - PubMed
    1. AlQarni K, AlQarni EA, Naqvi AA, et al.. Assessment of medication adherence in Saudi patients with type II diabetes mellitus in Khobar city, Saudi Arabia. Front Pharmacol 2019; 10: 1306. - PMC - PubMed
    1. Sakai R, Hashimoto Y, Ushigome E, et al.. Understanding of antidiabetic medication is associated with blood glucose in patients with type 2 diabetes: at baseline date of the KAMOGAWA-DM cohort study. J Diabetes Investig 2019; 10(2): 458. - PMC - PubMed

LinkOut - more resources